Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anti-influenza antibody cocktail (RenBio)
- Development stage
- Preclinical
- Lead developer
- Renbio
- Modality
- Gene Therapy Plasmids → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Intramuscular
01
Overview
RenBio's anti-influenza antibody cocktail is a preclinical-stage DNA-based therapeutic designed for the prevention of influenza. Utilizing the proprietary MYO (Make Your Own) Technology platform, the treatment involves the intramuscular delivery of plasmid DNA encoding specific antibodies via electroporation. Once delivered, muscle cells act as bioreactors, continuously producing and secreting therapeutic antibodies into the bloodstream for several months. This approach aims to provide broad and long-lasting protection against both seasonal and highly pathogenic influenza strains, potentially offering a more durable alternative to traditional protein-based antibody therapies or seasonal vaccines.
- Other names
- DNA-encoded anti-influenza antibody cocktailRenBio anti-influenza cocktailDNA-encoded antibody cocktail
02
Targets
NeuraminidaseHA (Hemagglutinin)
Beyond the preview
Go deeper on Anti-influenza antibody cocktail (RenBio).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anti-influenza antibody cocktail (RenBio).